These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2434227)

  • 1. Phase II study of vinblastine and bleomycin in advanced ovarian cancer.
    Osborne RJ; Harvey VJ; Slevin ML; Shepherd JH; Williams CJ
    Cancer Treat Rep; 1987 Mar; 71(3):335-6. PubMed ID: 2434227
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of bleomycin and mitomycin after failure of cisplatin and alkylating agent therapy in epithelial ovarian cancer.
    Lawton FG; Perren TJ; Luesley DM; Meanwell CA; Chan KK; Mould JJ; Blackledge G
    Cancer Treat Rep; 1986 Apr; 70(4):525-6. PubMed ID: 2421894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
    Sugiyama T; Yoshizaki A; Hatayama S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
    Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
    Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
    Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
    Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose cisplatinum, vinblastine, bleomycin, and etoposide in the therapy of malignant nondysgerminomatous germ cell tumors of the ovary.
    von Eyben FE
    Gynecol Oncol; 1995 Jul; 58(1):143. PubMed ID: 7540585
    [No Abstract]   [Full Text] [Related]  

  • 7. Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary.
    Sessa C; Bonazzi C; Landoni F; Pecorelli S; Sartori E; Mangioni C
    Obstet Gynecol; 1987 Aug; 70(2):220-4. PubMed ID: 2439966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
    Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
    Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of ovarian cancer].
    Kato T; Nishimura H
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract]   [Full Text] [Related]  

  • 10. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
    Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
    Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of ovarian germ cell tumor].
    Hayase R; Tamada T; Tao Y; Kohno I; Kudo T; Sekiba K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2655-8. PubMed ID: 2476076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of topotecan, carboplatin, and paclitaxel as front-line therapy in suboptimal advanced epithelial ovarian cancer.
    Bolis G; Scarfone G; Villa A; Parazzini F
    Gynecol Oncol; 2001 May; 81(2):331-3. PubMed ID: 11330974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early diagnosis and effective treatment of ovarian cancer].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1983 May; 10(5):1251-8. PubMed ID: 6191676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxicity and efficacy of chemotherapy dependent on circadian time of cytostatic drug administration].
    Zuchowska-Vogelgesang B; Pernal J; Zemełka T
    Przegl Lek; 1996; 53(12):870-3. PubMed ID: 9163011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma.
    Shah MK; St Marie K; Catalano RB; Dierks K; Creech RH
    Cancer Treat Rep; 1985 Feb; 69(2):229-30. PubMed ID: 3882232
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
    Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of the second-look operation in ovarian cancer.
    Schwartz PE
    Clin Obstet Gynaecol; 1983 Aug; 10(2):245-59. PubMed ID: 6193920
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
    Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
    Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate with leucovorin rescue, vinblastine, and bleomycin with or without tamoxifen in metastatic renal cell carcinoma.
    Bell DR; Aroney RS; Fisher RJ; Levi JA
    Cancer Treat Rep; 1984 Apr; 68(4):587-90. PubMed ID: 6201268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin, vinblastine, and bleomycin combination chemotherapy in a stage IV pure endodermal sinus tumor of the ovary--a case report of a long-term survival].
    Saito N; Kashimura Y; Soh T; Tsukamoto N
    Gan No Rinsho; 1988 Dec; 34(15):2114-8. PubMed ID: 2466134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.